Revelation Biosciences (REVB) Prepaid Assets (2020 - 2026)
Revelation Biosciences (REVB) posted quarterly Prepaid Assets of $111297.0 for Q4 2025, up 66.86% year-over-year from $66699.0 in Q4 2024, and down 10.2% quarter-over-quarter from $123934.0 in Q3 2025.
Revelation Biosciences (REVB) Prepaid Assets (2020 - 2026) Analysis & Trends
Revelation Biosciences (REVB) has reported Prepaid Assets for 6 consecutive years, with $111297.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 66.86% year-over-year to $111297.0; the TTM figure through Dec 2025 stood at $111297.0 (up 66.86% YoY), while the FY2025 annual figure was $111297.0, up 66.86% from the prior year.
- Prepaid Assets fell to $111297.0 in Q4 2025 per REVB's latest filing, from $123934.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $637342.0 in Q4 2021 and bottomed at $19334.0 in Q3 2021.
- Historically, Prepaid Assets has averaged $200510.3 across 5 years, with a median of $125128.0 in 2021.
- On a YoY basis, Prepaid Assets climbed as much as 966.88% in 2022 and fell as far as 88.53% in 2022.
- Revelation Biosciences' Prepaid Assets stood at $637342.0 in 2021, then sank by 88.53% to $73132.0 in 2022, then gained by 15.81% to $84691.0 in 2023, then declined by 21.24% to $66699.0 in 2024, then jumped by 66.86% to $111297.0 in 2025.
- Business Quant data shows REVB's Prepaid Assets at $111297.0 in Q4 2025, $123934.0 in Q3 2025, and $186049.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Revelation Biosciences | 4.17 Mn | -7.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 201,724.00 |
| Dec 31, 2025 | 111,297.00 |
| Sep 30, 2025 | 123,934.00 |
| Jun 30, 2025 | 186,049.00 |
| Mar 31, 2025 | 223,270.00 |
| Dec 31, 2024 | 66,699.00 |
| Sep 30, 2024 | 117,846.00 |
| Jun 30, 2024 | 125,743.00 |
| Mar 31, 2024 | 71,876.00 |
| Dec 31, 2023 | 84,691.00 |
| Sep 30, 2023 | 152,637.00 |
| Jun 30, 2023 | 250,012.00 |
| Mar 31, 2023 | 332,387.00 |
| Dec 31, 2022 | 73,132.00 |
| Sep 30, 2022 | 206,270.00 |
| Jun 30, 2022 | 412,500.00 |
| Mar 31, 2022 | 618,750.00 |
| Dec 31, 2021 | 637,342.00 |
| Sep 30, 2021 | 19,334.00 |
| Jun 30, 2021 | 71,924.00 |